Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [21] Multidrug-resistant tuberculosis
    Ellen M Zager
    Ruth McNerney
    BMC Infectious Diseases, 8
  • [22] Multidrug-resistant tuberculosis
    Caminero, Jose A.
    Garcia-Basteiro, Alberto L.
    Rendon, Adrian
    LANCET, 2019, 394 (10195): : 298 - 298
  • [23] Multidrug-Resistant Tuberculosis
    Spigelman, Mel
    Compton, Carolyn
    Gheuens, Jan
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22): : 2155 - 2155
  • [24] MULTIDRUG-RESISTANT TUBERCULOSIS
    GILLESPIE, SH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1995, 53 (07): : 305 - 307
  • [25] Multidrug-resistant tuberculosis
    Keertan Dheda
    Fuad Mirzayev
    Daniela Maria Cirillo
    Zarir Udwadia
    Kelly E. Dooley
    Kwok-Chiu Chang
    Shaheed Vally Omar
    Anja Reuter
    Tahlia Perumal
    C. Robert Horsburgh
    Megan Murray
    Christoph Lange
    Nature Reviews Disease Primers, 10
  • [26] Multidrug-resistant tuberculosis
    Seaworth, BJ
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (01) : 73 - +
  • [27] Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol
    Gama, Elvis
    Madan, Jason
    Langley, Ivor
    Girma, Mamo
    Evans, Denise
    Rosen, Sydney
    Squire, S. Bertel
    BMJ OPEN, 2016, 6 (10):
  • [28] Progress in global rollout of new multidrug-resistant tuberculosis treatments
    Held, K.
    McAnaw, S.
    Chiang, C-Y.
    Trebucq, A.
    Horsburgh, C. R., Jr.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (09) : 996 - +
  • [29] Screening for novel antituberculosis agents that are effective against multidrug resistant tuberculosis
    Matsumoto, Makoto
    Hashizume, Hiroyuki
    Tsubouchi, Hidetsugu
    Sasaki, Hirofumi
    Itotani, Motohiro
    Kuroda, Hideaki
    Tomishige, Tatsuo
    Kawasaki, Masanori
    Komatsu, Makoto
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (05) : 499 - 507
  • [30] The need to accelerate access to new drugs for multidrug-resistant tuberculosis
    Cox, Helen S.
    Furin, Jennifer J.
    Mitnick, Carole D.
    Daniels, Colleen
    Cox, Vivian
    Goemaere, Eric
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2015, 93 (07) : 491 - 497
12345